Ocrevus 300 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FNVBU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,019
Award facts
- Contract value 100% obligated
- $12,019.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,019.28 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials. This firm fixed price contract, awarded on July 23, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded, non-set-aside procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026.
Ocrevus is a specialty immunosuppressant medication used primarily in the treatment of multiple sclerosis, reflecting the Defense Health Agency's commitment to providing advanced therapeutic options to military personnel and beneficiaries. AmerisourceBergen Drug Corp's extensive federal contract portfolio with DLA demonstrates its established capability to deliver a wide range of pharmaceutical products and medical supplies to support military healthcare systems globally. The company's selection through open competition underscores its position as a critical vendor within the federal medical supply chain, capable of meeting stringent procurement requirements for specialized pharmaceutical products.
Quick answers
Who was awarded contract SPE2DB25FNVBU?
SPE2DB25FNVBU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FNVBU worth?
The government has obligated $12,019 on SPE2DB25FNVBU.
Is contract SPE2DB25FNVBU an order under another contract?
Yes. SPE2DB25FNVBU is a delivery order under SPE2DB25D3201, an indefinite delivery contract.
Was contract SPE2DB25FNVBU competed?
The extent of competition for SPE2DB25FNVBU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award